Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury
Translational Vision Science & Technology · 22.06.2023 · 12 (6) · 14
DOI: 10.1167/tvst.12.6.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, erschienen am 22.06.2023. Verfasst von Li Gong und 10 weiteren Autor:innen. Beteiligte Einrichtung: PriMed Non-human Primate Research Center of Sichuan PriMed Shines Bio-tech Co., Ltd., Ya'an, Sichuan Province, China. Hauptthemen laut MEDLINE: Macaca mulatta, Disease Models, Animal, Electroretinography, Reperfusion Injury. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To establish an inducible model of retinal ischemia/reperfusion injury (RI/RI) in nonhuman primates (NHPs) to improve our understanding of the disease conditions and evaluate treatment interventions in humans.
Methods
We cannulated the right eye of rhesus macaques with a needle attached to a normal saline solution reservoir at up to 1.9 m above the eye level that resulted in high intraocular pressure of over 100 mm Hg for 90 minutes. Retinal morphology and function were monitored before and after RI/RI over two months by fundus photography, optical coherence tomography, electroretinography, and visual evoked potential. Terminal experiments involved immunostaining for retinal ganglion cell marker Brn3a, glial fibrillary acidic protein, and quantitative polymerase chain reaction to assess retinal inflammatory biomarkers.
Results
We observed significant and progressive declines in retinal and retinal nerve fiber layer thickness in the affected eye after RI/RI. We noted significant reductions in amplitudes of electroretinography a-wave, b-wave, and visual evoked potential N2-P2, with minimal recovery at 63 days after injury. Terminal experiments conducted two months after injury revealed ∼73% loss of retinal ganglion cells and a fivefold increase in glial fibrillary acid protein immunofluorescence intensity compared to the uninjured eyes. We observed marked increases in tumor necrosis factor-alpha, interferon-gamma, interleukin-1beta, and inducible nitric oxide synthase in the injured retinas.
Conclusions
The results demonstrated that the pathophysiology observed in the NHP model of RI/RI is comparable to that of human diseases and suggest that the NHP model may serve as a valuable tool for translating interventions into viable treatment approaches. Translational Relevance: The model serves as a useful platform to study potential interventions and treatments for RI/RI or blinding retinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- PriMed Non-human Primate Research Center of Sichuan PriMed Shines Bio-tech Co., Ltd., Ya'an, Sichuan Province, China.
- Eye and Vision Research Institute at New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
- Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Gong, L., Pasquale, L. R., Wiggs, J. L., Pan, L., Yang, Z., Wu, M., Zeng, Z., Yang, Z., Shen, Y., Chen, D. F., & Zeng, W. (2023). Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury. Translational Vision Science & Technology, 12(6), 14. https://doi.org/10.1167/tvst.12.6.14
Vancouver
Gong L, Pasquale LR, Wiggs JL, Pan L, Yang Z, Wu M, et al. Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury. Translational Vision Science & Technology. 2023;12(6):14. doi:10.1167/tvst.12.6.14
BibTeX
@article{Gong2023,
author = {Gong, Li and Pasquale, Louis R and Wiggs, Janey L and Pan, Lingzhen and Yang, Zhenyan and Wu, Mingling and Zeng, Zirui and Yang, Zunyuan and Shen, Yubo and Chen, Dong Feng and Zeng, Wen},
title = {Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury},
journal = {Translational Vision Science & Technology},
year = {2023},
volume = {12},
number = {6},
pages = {14},
doi = {10.1167/tvst.12.6.14}
}
EUVIMED